与SARS相关的冠状病毒疫苗在子中的影响
Wentao Gao1, Azaibi Tamin, Adam Soloff
1Department of Surgery Molecular, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Lancet (London, England)
|December 12, 2003
概括
这项研究表明,表达SARS-CoV抗原的腺病毒疫苗可以在子中产生强烈的免疫反应. 这些发现为开发有效的严重急性呼吸系统综合征 (SARS) 疫苗提供了希望.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 严重急性呼吸系统综合征 (SARS) 是由新型冠状病毒引起的.
- 了解免疫反应对于开发SARS疫苗至关重要.
研究的目的:
- 为了研究SARS-CoV抗原的腺病毒传递,以诱导 rhesus的免疫力.
- 评估针对SARS-CoV的基于腺病毒的疫苗的潜力.
主要方法:
- rhesus 被肌肉内免疫,用编码 SARS-CoV 尖端蛋白 S1 片段,膜蛋白和核囊蛋白的腺病毒载体进行免疫.
- 在28日进行了增强疫苗接种.
- 分析了免疫反应,包括抗体和T细胞反应.
主要成果:
- 所有接种疫苗的动物都对尖蛋白S1片段产生了抗体反应.
- 观察到T细胞对核囊蛋白的反应.
- 在接种疫苗的中检测到强烈的体外中和抗体对SARS-CoV的反应.
结论:
- 基于腺病毒的疫苗可以在非人类灵长类动物中引起强大的SARS-CoV特异性免疫反应.
- 这种方法显示出保护性严重急性呼吸系统综合征 (SARS) 疫苗开发的潜力.
更多相关视频
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
相关概念视频
Vaccinations
Overview
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
